MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

As Trump made waves in Washington, many of his top Cabinet officials toured Europe, visiting Munich for a security conference ...

GREEN BAY – Brian Gutekunst gave it a solid effort. In two years after trading Davante Adams, the Green Bay Packers spent four draft picks on receivers, including second-round selections in ...

Hedge fund manager Bill Ackman just disclosed a position in Uber. Bill Ackman is one of the most closely followed investment ...

The Carolina Panthers could have wholesale changes at one major position on defense. Their method for reshaping that group ...

Wacker Chemie offers strong growth in semiconductors, solar, and biotech with a 60% upside. Click here to find out why WKCMF ...

Matt Rhule and his Nebraska football staff went into this recruiting cycle knowing there would be an eventual reduction in roster sizes. With a rather large roo ...

Nebraska's linebacker room is in the middle of a transition period. The defense is replacing all three second-level defenders who were multi-year starters for t ...

In his first season in Green Bay, Josh Jacobs challenged milestones in a Packers history loaded with elite running backs.

Recently, the firm has been leaning into its scale-driven cost advantage to emphasize its value offerings amid a challenging consumption spending environment. We view this strategy as prudent.